Abstract is: Hepatosplenic T-cell lymphoma is a rare form of lymphoma that is generally incurable, except in the case of an allogeneic stem cell transplant.It is a systemic neoplasm comprising medium-sized cytotoxic T-cells that show significant sinusoidal infiltration in the liver, spleen, and bone marrow.
| P557 | DiseasesDB | 34970 |
| P7807 | ICD-11 ID (Foundation) | 1301206942 |
| 801204949 | ||
| P7329 | ICD-11 ID (MMS) | 2A90.8 |
| P563 | ICD-O | 9716/3 |
| P6366 | Microsoft Academic ID | 2778929622 |
| 2909609683 | ||
| P1748 | NCI Thesaurus ID | C8459 |
| P1550 | Orphanet ID | 86882 |
| P2892 | UMLS CUI | C1333984 |
| P11143 | WikiProjectMed ID | Hepatosplenic T-cell lymphoma |
| P1995 | health specialty | oncology | Q162555 |
| Q91279132 | A Skin Plaque Preceding Systemic Relapse of Gamma-Delta Hepatosplenic T-Cell Lymphoma |
| Q37796190 | A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease |
| Q94670587 | A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation |
| Q34979481 | A seventeen-year-old female with hepatosplenic T-cell lymphoma associated with parvoviral infection |
| Q38252378 | Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party |
| Q64288553 | An unusual presentation of an uncommon lymphoma, hepatosplenic T-cell lymphoma |
| Q74343247 | CD26 expression and dipeptidyl peptidase IV activity in an aggressive hepatosplenic T-cell lymphoma |
| Q41893896 | CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma |
| Q92188315 | Case of a CD3 Negative Hepatosplenic T-Cell Lymphoma: Diagnostic and Therapeutic Challenges |
| Q53472513 | Childhood Hepatosplenic T-cell Lymphoma with Skin Involvement. |
| Q37719321 | Coexistent hairy cell leukaemia and hepatosplenic T-cell lymphoma: a case report |
| Q91090924 | Collapsing glomerulonephritis with podocyte markers in hemophagocytic syndrome secondary to hepatosplenic T-cell lymphoma |
| Q35101605 | Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus |
| Q90942379 | Complete Spontaneous Regression of Hepatosplenic T-Cell Lymphoma After Surgical Biopsy |
| Q46207882 | Crohn's disease, hepatosplenic T-cell lymphoma and no biological therapy: are we barking up the wrong tree? |
| Q53253105 | Cytogenetic and molecular characterization of a hepatosplenic T-cell lymphoma: report of a novel chromosomal aberration. |
| Q73292584 | Cytotoxic T-lymphocyte differentiation and cytogenetic alterations in gammadelta hepatosplenic T-cell lymphoma and posttransplant lymphoproliferative disorders |
| Q58596681 | DNA methylation profiling identifies candidate genes for the pathogenesis of hepatosplenic T-cell lymphoma |
| Q38224649 | De novo CD3 negative hepatosplenic T-cell lymphoma: diagnostic challenges and pitfalls |
| Q83455987 | Differential diagnosis of CD4-/CD8- γδ T-cell large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma |
| Q39276888 | Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis |
| Q33430888 | Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients |
| Q98291617 | Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report |
| Q88419486 | Expect the unexpected - Loss of surface CD3 on flow cytometry in hepatosplenic T-cell lymphoma: An eye opener |
| Q83984356 | F-18 flourodeoxyglucose positron emission tomography/computed tomography findings in a case of hepatosplenic T-cell lymphoma |
| Q38458081 | Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression |
| Q36458231 | Four hepatosplenic T-cell lymphoma cases of Japanese patients. |
| Q83286541 | Hematologic features of hepatosplenic T-cell lymphoma |
| Q73330909 | Hematologic malignancies with extramedullary spread of disease. Case 2. Hepatosplenic T-cell lymphoma |
| Q40210358 | Hemophacocytic syndrome as early sign for hepatosplenic T-cell lymphoma in a patient with chronic lymphocytic leukaemia |
| Q33723593 | Hemophagocytic lymphohistiocytosis associated with hepatosplenic T-cell lymphoma: case report |
| Q89196608 | Hepatosplenic T-Cell Lymphoma Arising in a Patient Treated With Tumor Necrosis Factor-α Inhibitors for Ankylosing Spondylitis |
| Q89919720 | Hepatosplenic T-Cell Lymphoma Diagnosed by Endoscopic Ultrasound-Guided Fine-Needle Biopsy |
| Q86981363 | Hepatosplenic T-Cell Lymphoma Mimicking Acute Myeloid Leukemia |
| Q42868041 | Hepatosplenic T-Cell Lymphoma in Inflammatory Bowel Disease: A Possible Thiopurine-Induced Chromosomal Abnormality |
| Q89992939 | Hepatosplenic T-Cell Lymphoma in an Immunocompetent Male with Central Nervous System Invasion: A Rare Clinical Entity |
| Q98290648 | Hepatosplenic T-Cell Lymphoma in an Immunocompetent Young Male: A Challenging Diagnosis |
| Q33425511 | Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Review With an Emphasis on Diagnostic Differentiation From Other T-Cell/Natural Killer-Cell Neoplasms |
| Q36812503 | Hepatosplenic T-Cell Lymphoma: A Population-Based Study Assessing Incidence and Association With Immune-Mediated Disease |
| Q92060101 | Hepatosplenic T-Cell Lymphoma: A Rare Complication of Monotherapy with Thiopurines in Crohn's Disease |
| Q50033986 | Hepatosplenic T-cell Lymphoma: A Review of Clinicopathologic Features, Pathogenesis and Prognostic Factors |
| Q95310465 | Hepatosplenic T-cell lymphoma (HSTCL) in patient with Crohn's disease treated with azathioprin |
| Q45207777 | Hepatosplenic T-cell lymphoma and TNF-α inhibitors |
| Q37814566 | Hepatosplenic T-cell lymphoma and inflammatory bowel disease |
| Q42189966 | Hepatosplenic T-cell lymphoma appearing in the peripheral blood |
| Q39050073 | Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review |
| Q52779359 | Hepatosplenic T-cell lymphoma associated with membranoproliferative glomerulonephritis. |
| Q46083530 | Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease |
| Q79629277 | Hepatosplenic T-cell lymphoma following infliximab therapy for Crohn's disease |
| Q39615429 | Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy |
| Q33343286 | Hepatosplenic T-cell lymphoma in a mare |
| Q37539703 | Hepatosplenic T-cell lymphoma in a patient with Crohn's disease |
| Q80573600 | Hepatosplenic T-cell lymphoma in a patient with Crohn's disease who received infliximab therapy |
| Q40111735 | Hepatosplenic T-cell lymphoma in a young immunocompetent man. |
| Q37725462 | Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review |
| Q36811485 | Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? |
| Q45256545 | Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease |
| Q37937410 | Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at risk |
| Q40315466 | Hepatosplenic T-cell lymphoma is a distinct rare entity: diagnosis by fine-needle aspiration cytology |
| Q87118816 | Hepatosplenic T-cell lymphoma mimicking bone marrow metastasis |
| Q74072016 | Hepatosplenic T-cell lymphoma of alphabeta lineage |
| Q33331768 | Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia |
| Q48111231 | Hepatosplenic T-cell lymphoma with aberrant expression of serum β-HCG: a case report. |
| Q48247202 | Hepatosplenic T-cell lymphoma with blastoid morphology in a patient with Crohn disease. |
| Q40082927 | Hepatosplenic T-cell lymphoma with coexistent hepatitis B infection: a rare clinicopathologic entity |
| Q38195339 | Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks? |
| Q46789474 | Hepatosplenic T-cell lymphoma: A case series |
| Q98212321 | Hepatosplenic T-cell lymphoma: A rare but challenging entity |
| Q56917155 | Hepatosplenic T-cell lymphoma: The problems of diagnosis and treatment |
| Q28298446 | Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin |
| Q33955993 | Hepatosplenic T-cell lymphoma: a rare cause of hepatosplenomegaly |
| Q53105612 | Hepatosplenic T-cell lymphoma: an acute leukemia presentation. |
| Q72787892 | Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation |
| Q44846429 | Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases |
| Q38100099 | Hepatosplenic T-cell lymphoma: is cure possible? |
| Q73643373 | Hepatosplenic T-cell lymphoma: prolymphocytic transformation 18 months after splenectomy |
| Q28307396 | Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta |
| Q71844458 | Hepatosplenic T-cell lymphoma: sinusoidal localization of malignant T-cells--a case report |
| Q74004471 | Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma |
| Q53243950 | Histopathological, immunophenotypic and clinical particularities and evolution of a case of hepatosplenic T-cell lymphoma in transformation to leukemia. |
| Q91753035 | How it looks at Autopsy? Hepatosplenic T-cell Lymphoma in a Patient of Crohn's Disease on Azathioprine |
| Q33384309 | Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia |
| Q48160916 | Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States. |
| Q33945848 | Integrative genomic and transcriptomic analysis identified candidate genes implicated in the pathogenesis of hepatosplenic T-cell lymphoma |
| Q91872738 | Intensive Induction Therapy Compared With CHOP for Hepatosplenic T-cell Lymphoma |
| Q33750759 | Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience |
| Q88419501 | Leukemic conversion of hepatosplenic T-cell lymphoma with pleomorphic morphology and an aggressive course |
| Q49930639 | Leukemic phase of hepatosplenic T-cell lymphoma: A great masquerader of acute leukemia |
| Q47916739 | Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma? |
| Q37187642 | Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets |
| Q33361242 | Morphologic, immunohistochemical, and molecular characterization of hepatosplenic T-cell lymphoma in a dog. |
| Q82768904 | NK-cell-associated receptor expression in hepatosplenic T-cell lymphoma, insights into pathogenesis |
| Q101451595 | Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience |
| Q57169319 | Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice-PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma |
| Q36944851 | Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen. |
| Q98830699 | Pralatrexate-based therapy induced response in an adolescent with refractory hepatosplenic T-cell lymphoma |
| Q40001357 | Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases |
| Q84551281 | Relapsed hepatosplenic T-cell lymphoma heralded by a solitary skin nodule |
| Q83885844 | Ring chromosome 7 with amplification of 7q sequences in a pediatric case of hepatosplenic T-cell lymphoma |
| Q38877202 | Simultaneous hepatosplenic T-cell lymphoma and myelofibrosis |
| Q93200590 | Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma |
| Q95532548 | Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant |
| Q34982820 | Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant |
| Q92992452 | Systematic review: hepatosplenic T-cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System |
| Q90784796 | Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma |
| Q92162234 | Tetrasomy 8 and isochromosome 7q in CD5-positive hepatosplenic T-cell lymphoma with leukemic presentation |
| Q37913261 | The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006. |
| Q88110750 | Two Cases of Hepatosplenic T-Cell Lymphoma in Adolescents Treated for Autoimmune Hepatitis |
| Q81736912 | [Clinicopathologic study of hepatosplenic T-cell lymphoma] |
| Q79812214 | [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report] |
| Q5208953 | Dahrran Diedrick | cause of death | P509 |